Clinical Trial Update: A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated single and multiple intravenous doses of SM17 in healthy subjects as part of asthma research and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SM17

Snippet

Sponsor: SinoMab BioScience Ltd | Conditions: Asthma | Phase 1 | Status: COMPLETED